Most studies focused on the correlations between plasma amyloid-β (Aβ) and clinical or pathologic aspects of AD [5–8], whereas a few recent researches have shifted the focus to plasma phosphorylated-tau (p-tau) [9–11]. This evidence concerns the gene MAPT and Alzheimer disease.